Product logins

Find logins to all Clarivate products below.


Interventional Oncology Devices | Market Analysis | Japan | 2019

The Japanese market for interventional oncology devices is growing at a slow rate, primarily due to preference for alternative treatments, strict regulations, and delays in the launch of new technologies.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the US across a 10-year period.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
ENT Devices – Market Insights – Japan
The Japanese ENT device market is projected to grow at a modest pace over the forecast period, supported by a slight increase in ENT procedure volumes. This growth will be primarily driven by a…
Report
Neurovascular Devices – Market Insights – Japan
The Japanese neurovascular device market will see modest growth through 2035, driven by recent technological and clinical advances, including the introduction of nextgeneration devices, expanding…
Report
Dialysis Access Treatment Devices – Market Insights – Japan
The Japanese dialysis access treatment device market will decline modestly through 2035, driven by the decreased patient population requiring dialysis care due to high mortality following COVID-19…
Report
Small-Joint Reconstructive Implants – Market Insights – Japan
The Japanese smalljoint reconstructive implant market, covering shoulder and elbow arthroplasty, exhibits longterm growth potential. Procedure volumes are rising steadily, driven by Japan’s…